Inve US ▾

Exelon (EXC) earnings

EXELON CORP· Utilities

Results to
Mar 2026
Latest analysed call
Jun 2026 (Q2 FY26)
Balance sheet to
Dec 2025

Company research is public. Sign in to keep your own companies, notes and cases.

Exelon earnings: last reported Thu, 30 Jul 2026, for the quarter ended Jun 2026.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue7,242 $ million+7.9% YoYQuarterly, as filedQuarter to Mar 2026Revenue from operations as filed.
Operating margin22.2 %−0.7 pts YoYOperating profit / revenueQuarter to Mar 2026For the quarter; a change is in percentage points.
Net profitUnavailable—Quarterly, as filedQuarter to Mar 2026Not in the filed figures for the quarter to mar 2026. No older figure is substituted.

Source: Inve data from filed results (SEC filings) · to Mar 2026

Guidance

What management said, and what became of it

12 of 12 judged targets kept · 32 open · verdicts reflect calls analysed to Jun 2026.

EXELON CORP management guidance track record: 44 targets tracked across analysed earnings calls (12 achieved, 0 missed, 32 open).

TargetOriginal wordingSaidLatest callVerdict
File a BGE base rate case in Marylandfile the next BGE rate case in 2026, probably in the first halfDec 2025Jun 2026:Earlier this month, we also filed a rate case at BGE with the decision expected in January 2027
Call transcript, Jun 2026 · no direct link
Achieved
Full-year adjusted operating earnings per share$2.81 to $2.91 per shareDec 2025Jun 2026:We remain on track to deliver full year operating earnings of $2.81 to $2.91 per share, with the goal to be at the midpoint or better
Call transcript, Jun 2026 · no direct link
On Track
Adjusted O&M expense growth through 2029no more than 2.5% adjusted O&M growth through 2029Dec 2025Mar 2026:we are now targeting no more than 2% adjusted O&M growth through 2029
Call transcript, Mar 2026 · no direct link
Revised Up

A verdict describes what became of management’s own words in later analysed calls. “Delayed” is a change of date, “went quiet” a target the calls stopped mentioning. None of it is a judgement on the investment. The methodology sets out how verdicts are recorded.

32 of EXELON CORP's 44 targets are still open. See which are on track and which have gone quiet. The 3 above are the free sample; 41 more targets are in the full ledger.

Free account: 5 full ledgers a month and one Inve Case. US Pro opens 100 a month: first month free, no card.
See the full record

Price

$42.41 −2.51% · −$1.09

Last close Oct 19, 2026 · US · USD

Performance −11.2% 1Y

$40.0$42.0$44.0$46.0$48.0$50.0Oct 25Dec 25Jan 26Mar 26Apr 26Jun 26Jul 26Aug 26Oct 26Sep 2025 (Q3 FY25) — 4 Nov 2025Dec 2025 (Q4 FY25) — 12 Feb 2026Mar 2026 (Q1 FY26) — 6 May 2026Jun 2026 (Q2 FY26) — 30 Jul 2026

1Y: $47.78 on 17 Oct 2025 → $42.41. High $50.29 (16 Mar 2026), low $40.2 (24 Sept 2026).

Previous close
$43.5
52-week range
$40.2 – $50.29
One year
−12.09%

Overview

Symbol
EXC
Sector
Utilities
Exchange
US
Currency
USD

Your own record

Start an Inve Case for EXELON CORP

Free account. Everything above stays public.

Write why you follow EXELON CORP and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.

What an account adds